| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $117.9M | -10.7% |
| Cost of Revenue | $26.4M | -9.2% |
| Gross Profit | $91.5M | -11.1% |
| R&D Expense | $700K | -12.5% |
| SG&A Expense | $41.7M | -14.2% |
| Operating Income | $1.4M | +248.2% |
| Pre-tax Income | $3.7M | +431.0% |
| Income Tax | $1.3M | +12.7% |
| Net Income | $2.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | +47.4% |
| Accounts Receivable | $19K | -79.1% |
| Inventory | $10.4M | -28.4% |
| Current Assets | $26.1M | -5.6% |
| Total Assets | $36.1M | -12.5% |
| Current Liabilities | $20.9M | -18.9% |
| Total Liabilities | $27.4M | -10.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.3M | +195.4% |
| Capital Expenditures | $297K | -60.3% |
| Investing Cash Flow | -$285K | +61.8% |
| Financing Cash Flow | $2.0M | +203.0% |
| Free Cash Flow | $2.0M | +163.0% |
| +211.2% |
| EPS (Basic) | $1.32 | +210.0% |
| EPS (Diluted) | $1.32 | +210.0% |
| Stockholders' Equity |
| $8.6M |
| -17.8% |